Initiator Pharma A/S

Initiator Pharma A/S EBITDA per Share

The EBITDA per Share of Initiator Pharma A/S (INIT.ST) as of Nov 3, 2026 is -0.27 DKK. In the previous year, EBITDA per Share was 0.01 DKK — a change of -4,769.40% (lower).

EBITDA per Share

-0.27DKK

YoY

-4,769.40%

Last updated:

EBITDA per Share of Initiator Pharma A/S is 2025 -0.27 DKK. EBITDA per Share of Initiator Pharma A/S was 2024 0.01 DKK. It decreases by -4,769.40% lower compared to the previous year.

The Initiator Pharma A/S EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
0.00 DKK
Jan 1, 2019
0.00 DKK
Jan 1, 2020
0.00 DKK
Jan 1, 2021
0.02 DKK
Jan 1, 2022
-0.66 DKK
Jan 1, 2023
0.04 DKK
Jan 1, 2024
0.01 DKK
Jan 1, 2025
-0.27 DKK
The Initiator Pharma A/S EBITDA per Share history
YEAREBITDA per ShareYoY
-0.27DKK-4,769.40%
0.01DKK-86.51%
0.04DKK-106.43%
-0.66DKK-3,861.73%
0.02DKK+1,981.81%
0.00DKK-73.63%
0.00DKK-27.12%
0.00DKK-33.50%
0.01DKK+707.83%
0.00DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Initiator Pharma A/S Stock analysis

What does Initiator Pharma A/S do? Initiator Pharma A/S is a clinical-stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops novel therapeutics targeting monoamine reuptake transporters for central nervous system disorders, with a focus on erectile dysfunction treatments. Initiator Pharma A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Initiator Pharma A/S stock

EBITDA per Share of Initiator Pharma A/S is -0.27 DKK in 2025.

EBITDA per Share of Initiator Pharma A/S changed from 0.01 DKK to -0.27 DKK, representing a -4,769.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Initiator Pharma A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Initiator Pharma A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Initiator Pharma A/S